![Week 7 Art. 102 TFEU - WEEK 7 - ARTICLE 102 TFEU AND MARKET DEFINITION READING Literature Barnard - Studeersnel Week 7 Art. 102 TFEU - WEEK 7 - ARTICLE 102 TFEU AND MARKET DEFINITION READING Literature Barnard - Studeersnel](https://d20ohkaloyme4g.cloudfront.net/img/document_thumbnails/300f0272a6d8e0993947e86761c46d0a/thumb_1200_1553.png)
Week 7 Art. 102 TFEU - WEEK 7 - ARTICLE 102 TFEU AND MARKET DEFINITION READING Literature Barnard - Studeersnel
![A representative of Swiss-based Hoffmann-La Roche shows the antiviral drug Tamiflu at her pharmaceutical in Phnom Penh October 7, 2005. [Swiss drug maker Roche urged consumers on Friday not to buy its A representative of Swiss-based Hoffmann-La Roche shows the antiviral drug Tamiflu at her pharmaceutical in Phnom Penh October 7, 2005. [Swiss drug maker Roche urged consumers on Friday not to buy its](https://c8.alamy.com/comp/2D2D0WH/a-representative-of-swiss-based-hoffmann-la-roche-shows-the-antiviral-drug-tamiflu-at-her-pharmaceutical-in-phnom-penh-october-7-2005-swiss-drug-maker-roche-urged-consumers-on-friday-not-to-buy-its-flu-drug-tamiflu-over-the-internet-to-avoid-the-risk-of-potentially-purchasing-counterfeit-pills-as-they-build-stockpiles-in-case-of-a-bird-flu-pandemic-2D2D0WH.jpg)
A representative of Swiss-based Hoffmann-La Roche shows the antiviral drug Tamiflu at her pharmaceutical in Phnom Penh October 7, 2005. [Swiss drug maker Roche urged consumers on Friday not to buy its
![Hoffmann-La Roche: Pricing the Zelboraf Melanoma Treatment for Canada Case Solution And Analysis, HBR Case Study Solution & Analysis of Harvard Case Studies Hoffmann-La Roche: Pricing the Zelboraf Melanoma Treatment for Canada Case Solution And Analysis, HBR Case Study Solution & Analysis of Harvard Case Studies](https://www.thecasesolutions.com/wp-content/uploads/imgs/hoffmannla%20roche%20pricing%20the%20zelboraf%20melanoma%20treatment%20for%20canada.jpeg)
Hoffmann-La Roche: Pricing the Zelboraf Melanoma Treatment for Canada Case Solution And Analysis, HBR Case Study Solution & Analysis of Harvard Case Studies
![EPLR - European Pharmaceutical Law Review: An Eye for an Eye? Off-label Use and Misleading Information: Hoffmann-La Roche v AGCM EPLR - European Pharmaceutical Law Review: An Eye for an Eye? Off-label Use and Misleading Information: Hoffmann-La Roche v AGCM](https://eplr.lexxion.eu/data/article_preview/12877/medium.jpg)
EPLR - European Pharmaceutical Law Review: An Eye for an Eye? Off-label Use and Misleading Information: Hoffmann-La Roche v AGCM
Case C-179/16 F. Hoffmann-La Roche and Novartis – ECJ finds concerted efforts to restrict off-label use of medicinal products
![Projecting a vision for business in society: André Hoffmann, Roche: Family Business Survey 2018: PwC Projecting a vision for business in society: André Hoffmann, Roche: Family Business Survey 2018: PwC](https://www.pwc.com/gx/en/family-business-services/family-business-survey-2018/case-studies/andre-hoffmann-roche.jpg)